Details for New Drug Application (NDA): 012302
✉ Email this page to a colleague
NDA 012302 describes CHOLOXIN, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the CHOLOXIN profile page.
The generic ingredient in CHOLOXIN is dextrothyroxine sodium. There is one drug master file entry for this compound. Additional details are available on the dextrothyroxine sodium profile page.
The generic ingredient in CHOLOXIN is dextrothyroxine sodium. There is one drug master file entry for this compound. Additional details are available on the dextrothyroxine sodium profile page.
Summary for 012302
| Tradename: | CHOLOXIN |
| Applicant: | Abbvie |
| Ingredient: | dextrothyroxine sodium |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
